{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:26:57Z","timestamp":1793734017639,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China (CN)","award":["81571171"],"award-info":[{"award-number":["81571171"]}]},{"name":"Shandong Province Science and Technology Plan","award":["2017GSF218030"],"award-info":[{"award-number":["2017GSF218030"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2017MH010"],"award-info":[{"award-number":["ZR2017MH010"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1289-z","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T20:05:51Z","timestamp":1535573151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Li","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"1289_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39:889\u2013909.","journal-title":"Neuron"},{"key":"1289_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"1289_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106:518\u201326.","journal-title":"Acta Neuropathol"},{"key":"1289_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"1289_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180:147\u201350.","journal-title":"Neurosci Lett"},{"key":"1289_CR6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/mcne.2000.0914","volume":"16","author":"C Knott","year":"2000","unstructured":"Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci. 2000;16:724\u201339.","journal-title":"Mol Cell Neurosci"},{"key":"1289_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0006-8993(89)90857-3","volume":"489","author":"H Akiyama","year":"1989","unstructured":"Akiyama H, McGeer PL. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 1989;489:247\u201353.","journal-title":"Brain Res"},{"key":"1289_CR8","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","volume":"18","author":"AM Depino","year":"2003","unstructured":"Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson\u2019s disease. Eur J Neurosci. 2003;18:2731\u201342.","journal-title":"Eur J Neurosci"},{"key":"1289_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflammation. 2008;5:8.","journal-title":"J Neuroinflammation"},{"key":"1289_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","volume":"15","author":"F Cicchetti","year":"2002","unstructured":"Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci. 2002;15:991\u20138.","journal-title":"Eur J Neurosci"},{"key":"1289_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M Kohutnicka","year":"1998","unstructured":"Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A. Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 1998;39:167\u201380.","journal-title":"Immunopharmacology"},{"key":"1289_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/exnr.1998.6993","volume":"156","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, Czlonkowski A, Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol. 1999;156:50\u201361.","journal-title":"Exp Neurol"},{"key":"1289_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","volume":"341","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Kim JH, Greenamyre JT. Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease. Neurosci Lett. 2003;341:87\u201390.","journal-title":"Neurosci Lett"},{"key":"1289_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1742-2094-8-137","volume":"8","author":"J Drouin-Ouellet","year":"2011","unstructured":"Drouin-Ouellet J, Gibrat C, Bousquet M, Calon F, Kriz J, Cicchetti F. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration. J Neuroinflammation. 2011;8:137.","journal-title":"J Neuroinflammation"},{"key":"1289_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","volume":"22","author":"G Dutta","year":"2008","unstructured":"Dutta G, Zhang P, Liu B. The lipopolysaccharide Parkinson\u2019s disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol. 2008;22:453\u201364.","journal-title":"Fundam Clin Pharmacol"},{"key":"1289_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N. Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia. 2013;61:349\u201360.","journal-title":"Glia"},{"key":"1289_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"C Noelker","year":"2013","unstructured":"Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, et al. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep. 2013;3:1393.","journal-title":"Sci Rep"},{"key":"1289_CR18","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG, Beraud D, Davenport C, Cheng K, Yin H, Maguire-Zeiss KA. Activation of MyD88-dependent TLR1\/2 signaling by misfolded alpha-synuclein, a protein linked to neurodegenerative disorders. Sci Signal. 2015;8:ra45.","journal-title":"Sci Signal"},{"key":"1289_CR19","doi-asserted-by":"publisher","first-page":"16091","DOI":"10.1523\/JNEUROSCI.2400-10.2010","volume":"30","author":"M Deleidi","year":"2010","unstructured":"Deleidi M, Hallett PJ, Koprich JB, Chung CY, Isacson O. The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. J Neurosci. 2010;30:16091\u2013101.","journal-title":"J Neurosci"},{"key":"1289_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20150617","volume":"471","author":"A Gustot","year":"2015","unstructured":"Gustot A, Gallea JI, Sarroukh R, Celej MS, Ruysschaert JM, Raussens V. Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem J. 2015;471:323\u201333.","journal-title":"Biochem J"},{"key":"1289_CR21","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One. 2013;8:e55375.","journal-title":"PLoS One"},{"key":"1289_CR22","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869\u201372.","journal-title":"J Biol Chem"},{"key":"1289_CR23","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.4049\/jimmunol.178.4.2380","volume":"178","author":"JH Park","year":"2007","unstructured":"Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Nunez G. RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol. 2007;178:2380\u20136.","journal-title":"J Immunol"},{"key":"1289_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature. 2001;411:603\u20136.","journal-title":"Nature"},{"key":"1289_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature"},{"key":"1289_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19\u201320.","journal-title":"Nat Genet"},{"key":"1289_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105:1195\u20137.","journal-title":"Blood"},{"key":"1289_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.neures.2006.11.012","volume":"57","author":"M Bialecka","year":"2007","unstructured":"Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Juzwiak S, Kurzawski G, Tan EK, Drozdzik M. CARD15 variants in patients with sporadic Parkinson\u2019s disease. Neurosci Res. 2007;57:473\u20136.","journal-title":"Neurosci Res"},{"key":"1289_CR29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/mds.25059","volume":"27","author":"S Appenzeller","year":"2012","unstructured":"Appenzeller S, Thier S, Papengut F, Klein C, Hagenah J, Kasten M, Berg D, Srulijes K, Gasser T, Schreiber S, et al. No association between NOD2 variants and Parkinson\u2019s disease. Mov Disord. 2012;27:1191\u20132.","journal-title":"Mov Disord"},{"key":"1289_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1744-9081-9-19","volume":"9","author":"Q Ma","year":"2013","unstructured":"Ma Q, An X, Li Z, Zhang H, Huang W, Cai L, Hu P, Lin Q, Tzeng CM. P268S in NOD2 associates with susceptibility to Parkinson\u2019s disease in Chinese population. Behav Brain Funct. 2013;9:19.","journal-title":"Behav Brain Funct"},{"key":"1289_CR31","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s11064-016-2148-x","volume":"42","author":"L Chen","year":"2017","unstructured":"Chen L, Cheng L, Wei X, Yuan Z, Wu Y, Wang S, Ren Z, Liu X, Liu H. Tetramethylpyrazine analogue CXC195 protects against dopaminergic neuronal apoptosis via activation of PI3K\/Akt\/GSK3beta signaling pathway in 6-OHDA-induced Parkinson\u2019s disease mice. Neurochem Res. 2017;42:1141\u201350.","journal-title":"Neurochem Res"},{"key":"1289_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2017.08.028","volume":"815","author":"L Chen","year":"2017","unstructured":"Chen L, Ren Z, Wei X, Wang S, Wang Y, Cheng Y, Gao H, Liu H. Losartan protects against cerebral ischemia\/reperfusion-induced apoptosis through beta-arrestin1-mediated phosphorylation of Akt. Eur J Pharmacol. 2017;815:98\u2013108.","journal-title":"Eur J Pharmacol"},{"key":"1289_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7150\/ijbs.10927","volume":"11","author":"H Liu","year":"2015","unstructured":"Liu H, Wei X, Kong L, Liu X, Cheng L, Yan S, Zhang X, Chen L. NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species. Int J Biol Sci. 2015;11:525\u201335.","journal-title":"Int J Biol Sci"},{"key":"1289_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jchromb.2011.02.011","volume":"879","author":"KY Zhu","year":"2011","unstructured":"Zhu KY, Fu Q, Leung KW, Wong ZC, Choi RC, Tsim KW. The establishment of a sensitive method in determining different neurotransmitters simultaneously in rat brains by using liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:737\u201342.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1289_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"},{"key":"1289_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/glia.20770","volume":"57","author":"VS Chauhan","year":"2009","unstructured":"Chauhan VS, Sterka DG Jr, Furr SR, Young AB, Marriott I. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia. 2009;57:414\u201323.","journal-title":"Glia"},{"key":"1289_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"1289_CR38","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1073\/pnas.1432609100","volume":"100","author":"S Lehnardt","year":"2003","unstructured":"Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003;100:8514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1289_CR39","doi-asserted-by":"publisher","first-page":"51647","DOI":"10.1074\/jbc.M407328200","volume":"279","author":"H Arai","year":"2004","unstructured":"Arai H, Furuya T, Yasuda T, Miura M, Mizuno Y, Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice. J Biol Chem. 2004;279:51647\u201353.","journal-title":"J Biol Chem"},{"key":"1289_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.04.037","volume":"97","author":"BW Kim","year":"2015","unstructured":"Kim BW, Koppula S, Kumar H, Park JY, Kim IW, More SV, Kim IS, Han SD, Kim SK, Yoon SH, Choi DK. alpha-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson\u2019s disease. Neuropharmacology. 2015;97:46\u201357.","journal-title":"Neuropharmacology"},{"key":"1289_CR41","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1002\/ana.410440721","volume":"44","author":"NA Tatton","year":"1998","unstructured":"Tatton NA, Maclean-Fraser A, Tatton WG, Perl DP, Olanow CW. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson\u2019s disease. Ann Neurol. 1998;44:S142\u20138.","journal-title":"Ann Neurol"},{"key":"1289_CR42","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol. 1997;12:25\u201331.","journal-title":"Histol Histopathol"},{"key":"1289_CR43","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.4049\/jimmunol.0903065","volume":"184","author":"AA Shigeoka","year":"2010","unstructured":"Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB. Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol. 2010;184:2297\u2013304.","journal-title":"J Immunol"},{"key":"1289_CR44","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJMra022366","volume":"348","author":"RM Friedlander","year":"2003","unstructured":"Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365\u201375.","journal-title":"N Engl J Med"},{"key":"1289_CR45","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2000;97:2875\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1289_CR46","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1073\/pnas.051633998","volume":"98","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2001;98:2837\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1289_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/ars.2005.7.1117","volume":"7","author":"GD Zeevalk","year":"2005","unstructured":"Zeevalk GD, Bernard LP, Song C, Gluck M, Ehrhart J. Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration. Antioxid Redox Signal. 2005;7:1117\u201339.","journal-title":"Antioxid Redox Signal"},{"key":"1289_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1096\/fj.05-4553com","volume":"20","author":"ML Block","year":"2006","unstructured":"Block ML, Li G, Qin L, Wu X, Pei Z, Wang T, Wilson B, Yang J, Hong JS. Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J. 2006;20:251\u20138.","journal-title":"FASEB J"},{"key":"1289_CR49","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1073\/pnas.0937239100","volume":"100","author":"DC Wu","year":"2003","unstructured":"Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2003;100:6145\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1289_CR50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","volume":"103","author":"J Rodriguez-Pallares","year":"2007","unstructured":"Rodriguez-Pallares J, Parga JA, Munoz A, Rey P, Guerra MJ, Labandeira-Garcia JL. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem. 2007;103:145\u201356.","journal-title":"J Neurochem"},{"key":"1289_CR51","doi-asserted-by":"publisher","first-page":"e75532","DOI":"10.1371\/journal.pone.0075532","volume":"8","author":"MS Hernandes","year":"2013","unstructured":"Hernandes MS, Santos GD, Cafe-Mendes CC, Lima LS, Scavone C, Munhoz CD, Britto LR. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration. PLoS One. 2013;8:e75532.","journal-title":"PLoS One"},{"key":"1289_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.freeradbiomed.2014.12.013","volume":"79","author":"J Shang","year":"2015","unstructured":"Shang J, Wan Q, Wang X, Duan Y, Wang Z, Wei X, Zhang Y, Wang H, Wang R, Yi F. Identification of NOD2 as a novel target of RNA-binding protein HuR: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy. Free Radic Biol Med. 2015;79:217\u201327.","journal-title":"Free Radic Biol Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1289-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:30:13Z","timestamp":1751823013000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1289-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1289-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee at Shandong University, and the reference number is LL-201502008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"243"}}